NewslettersESC & iPSC NewsGameto Announces FDA IND Clearance for Fertilo, the First iPSC-Based Therapy to Enter US Phase III Clinical TrialsBy Emily Salmini - February 4, 2025023Gameto announced that the US FDA has cleared its Investigational New Drug (IND) application for Fertilo, to enable the launch of the first US-based Phase III clinical trial for an iPSC-based therapy.[Gameto (Businesswire)]Press Release